The approval of medicines called second-generation antipsychotics has allowed bipolar I and other associated conditions to be treated. A person with bipolar I disorder can go through various mood ...

Some people experience weight gain during treatment with Vraylar. While exercise may be helpful, it’s crucial not to overheat or dehydrate. Taking Vraylar can affect your metabolism, such as ...

Vraylar (cariprazine) is a powerful antipsychotic medication that is approved by the Food and Drug Administration (FDA) to treat schizophrenia, bipolar disorder, and major depressive disorder (MDD).

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

Vraylar (cariprazine) is a prescription drug that helps treat certain mental health conditions. The drug comes as an oral capsule. Vraylar may not be safe to take while pregnant or breastfeeding. Keep ...

It’s not known whether Vraylar is safe to take while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition during pregnancy, may determine whether you should ...

The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults. "Schizophrenia and bipolar disorder can be disabling and can ...

A patient with depression says she was "stuck" until AbbVie's Vraylar gave her "a lift," which is the theme of the company's latest ad campaign for the mental health drug. Vraylar, a sales blockbuster ...

Many people with major depressive disorder don’t get enough relief from their symptoms despite antidepressant medication. To potentially rectify the problem, the U.S. Food and Drug Administration (FDA ...

AbbVie’s new $8.7 billion buyout of psychiatric biotech Cerevel sees it gain a key midstage pipeline med in emraclidine, and the pharma says it will lean on its marketing work for its atypical ...